A detailed history of Alliancebernstein L.P. transactions in Quanterix Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,265,603 shares of QTRX stock, worth $38.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,265,603
Previous 3,414,794 4.37%
Holding current value
$38.5 Million
Previous $45.1 Million 6.25%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.92 - $16.36 $1.63 Million - $2.44 Million
-149,191 Reduced 4.37%
3,265,603 $42.3 Million
Q2 2024

Aug 14, 2024

BUY
$12.26 - $23.78 $10.8 Million - $21 Million
883,266 Added 34.89%
3,414,794 $45.1 Million
Q1 2024

May 14, 2024

BUY
$21.9 - $28.28 $43.2 Million - $55.7 Million
1,971,203 Added 351.8%
2,531,528 $59.6 Million
Q4 2023

Feb 14, 2024

BUY
$19.54 - $28.66 $10.2 Million - $14.9 Million
520,125 Added 1293.84%
560,325 $15.3 Million
Q4 2022

Feb 14, 2023

BUY
$8.75 - $14.02 $96,250 - $154,220
11,000 Added 37.67%
40,200 $556,000
Q3 2022

Nov 15, 2022

SELL
$7.46 - $19.28 $32,824 - $84,832
-4,400 Reduced 13.1%
29,200 $322,000
Q2 2021

Jul 30, 2021

BUY
$43.3 - $67.17 $411,350 - $638,115
9,500 Added 39.42%
33,600 $1.97 Million
Q1 2021

May 06, 2021

BUY
$44.11 - $90.64 $229,372 - $471,328
5,200 Added 27.51%
24,100 $1.41 Million
Q3 2020

Nov 12, 2020

SELL
$26.91 - $37.47 $40,365 - $56,205
-1,500 Reduced 7.35%
18,900 $638,000
Q1 2020

May 14, 2020

BUY
$11.17 - $28.72 $37,978 - $97,648
3,400 Added 20.0%
20,400 $375,000
Q2 2019

Aug 14, 2019

BUY
$20.59 - $35.2 $107,068 - $183,040
5,200 Added 44.07%
17,000 $574,000
Q1 2019

May 14, 2019

BUY
$17.28 - $25.83 $203,904 - $304,794
11,800 New
11,800 $305,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.